Stocks and InvestingStocks and Investing
Mon, July 11, 2022
Sun, July 10, 2022
Fri, July 8, 2022
Thu, July 7, 2022

Graig Suvannavejh Initiated (ATHA) at Strong Buy and Held Target at $6 on, Jul 7th, 2022


Published on 2024-10-27 21:47:25 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Initiated "Athira Pharma, Inc." (ATHA) at Strong Buy and Held Target at $6 on, Jul 7th, 2022.

Graig has made no other calls on ATHA in the last 4 months.



There are 5 other peers that have a rating on ATHA. Out of the 5 peers that are also analyzing ATHA, 3 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Tsai of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $3 on, Thursday, June 23rd, 2022
  • Jason Butler of "JMP Securities" Downgraded from Buy to Hold on, Thursday, June 23rd, 2022
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Thursday, June 23rd, 2022


These are the ratings of the 2 analyists that currently disagree with Graig


  • Thomas Shrader of "BTIG" Initiated at Strong Buy and Held Target at $33 on, Tuesday, May 10th, 2022
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022